Synteract

De Kleetlaan 5

1830 Machelen

BE

Synteract

Foundation date

29/02/1996

Sector

#Biotechnology / R&D Services

Subsector

In February 2013, San Diego-based Synteract acquired Munich-based Harrison Clinical Research – and expanded our services and strength to the Power of Two – two excellent CROs that, together as one, deliver international, full-service clinical trial services.

Upcoming events

Latest news

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    18 hours ago

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022

  • Pauwels Consulting takes over Science@Work

    Friday September 23rd 2022